Industry Partnerships & Technology Transfer Office | CAMH

Technology Transfer

Dr. Aristotle Voineskos.

Research commercialization and industry partnerships can serve as a critical step in the advancement of science to the bedside; it can catalyze our ability to carry an innovative idea through the discovery pipeline for the benefit of patients worldwide.

Aristotle Voineskos, Senior Vice President of Research and Science & Director of the Campbell Family Mental Health Research Institute

New CAMH-Developed Drug Shows Promise in Reversing Memory Loss for Early Alzheimer's Patients

Pre-clinical trial suggests treatment may slow the progression of Alzheimer’s and restore cognitive function.

Dr. Jeff Meyer holding up his nutraceutical product

CAMH develops first ever clinically validated natural supplement to prevent postpartum blues

Product now available in the U.S. with global distribution planned

Picture of mobile phone showing new schizophrenia app

Living with schizophrenia? There may soon be an app for that

Beta version of app uses a Facebook-like platform designed for people with schizophrenia and other psychoses.